Comparison of VTD (velcade-thalidomide-dexamethasone) and a conventional chemotherapy induction regimen: effect on stem cell mobilization and engraftment of ASCT (autologous stem cell transplantation) for newly diagnosed multiple myeloma

被引：0
|
作者：
Requena, M. J. [1 ]
Yebra, E. [1 ]
Berberana, M. [1 ]
Payamps, C. [1 ]
Diaz Goizueta, M. [1 ]
Riaza, R. [1 ]
Penalver, M. A. [1 ]
Rodriguez, R. [1 ]
Sanchez Godoy, P. [1 ]
机构：
[1] Hosp Severo Ochoa, Madrid, Spain
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S212 / S213
页数：2
相关论文
共 50 条
  • [21] Cyclophosphamide-based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma
    Tuchman, Sascha A.
    Bacon, Wendi A.
    Huang, Li-Wen
    Long, Gwynn
    Rizzieri, David
    Horwitz, Mitchell
    Chute, John P.
    Sullivan, Keith
    Engemann, Ashley Morris
    Yopp, Amanda
    Li, Zhiguo
    Corbet, Kelly
    Chao, Nelson
    Gasparetto, Cristina
    JOURNAL OF CLINICAL APHERESIS, 2015, 30 (03) : 176 - 182
  • [22] Influence of stem cell mobilisation after cyclophosphamide, thalidomide and dexamethasone regimen in patients with newly diagnosed multiple myeloma
    Lee, J. J.
    Ahn, J. S.
    Yang, D. H.
    Jung, S. H.
    Song, C. E.
    Choi, G. H.
    Lee, S. Y.
    Bae, S. Y.
    Kim, Y. K.
    Kim, H. J.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S332 - S332
  • [23] SAFETY AND EARLY EFFICACY OF TANDEM AUTOLOGOUS STEM-CELL TRANSPLANTATION AFTER DARATUMUMAB VTD INDUCTION IN NEWLY DIAGNOSED MULTIPLE MYELOMA
    Liberatore, Carmine
    Rossi, Elena
    Malerba, Lara
    Fioritoni, Francesca
    Di Landro, Francesca
    Fazio, Francesca
    Ferraro, Silvia
    Antolino, Giusy
    De Padua, Laura
    Coppetelli, Ugo
    Bongarzoni, Velia
    Pulini, Stefano
    Chiusolo, Patrizia
    Vaddinelli, Doriana
    Natale, Annalisa
    Visani, Giuseppe
    De Stefano, Valerio
    Di Ianni, Mauro
    BONE MARROW TRANSPLANTATION, 2024, 59 : 514 - 515
  • [24] Bortezomib (Velcade) for progressive myeloma after autologous stem cell transplantation and thalidomide
    Musto, P
    Falcone, A
    Sanpaolo, G
    Guglielmelli, T
    Zambello, R
    Balleari, E
    Catalano, L
    Spriano, M
    Cavallo, F
    La Sala, A
    Mantuano, S
    Nobile, M
    Melillo, L
    Scalzulli, PR
    Dell'Olio, M
    Bodenizza, C
    Greco, MM
    Carella, AM
    Merla, E
    Carella, AM
    Boccadoro, M
    Cascavilla, N
    Palumbo, A
    LEUKEMIA RESEARCH, 2006, 30 (03) : 283 - 285
  • [25] INDUCTION THERAPY WITH BORTEZOMIB-THALIDOMIDE-DEXAMETHASONE (VTD) DOES NOT IMPAIRE AUTOLOGOUS PERIPHERAL BLOOD STEM-CELL (PBSC) COLLECTION IN NEWLY DIAGNOSED MULTIPLE MYELOMA (MM)
    Brioli, A.
    Perrone, G.
    Galli, M.
    Di Raimondo, F.
    Bringhen, S.
    Motta, M. R.
    Montefusco, V.
    Spadano, T.
    Pescosta, N.
    Ledda, A.
    Falcone, A.
    Pezzi, A.
    Zambello, R.
    Gherlinzoni, F.
    Zannetti, B.
    Ballanti, S.
    Petti, M.
    Marcatti, M.
    Rizzi, S.
    Nozza, A.
    Califano, C.
    Baccarani, M.
    Cavo, M.
    HAEMATOLOGICA, 2012, 97 : 177 - 178
  • [26] Bortezomib-thalidomide-dexamethasone (VTD) is superior to bortezomib-cyclophosphamide-dexamethasone (VCD) as induction therapy prior to autologous stem cell transplantation in multiple myeloma
    M Cavo
    L Pantani
    A Pezzi
    M T Petrucci
    F Patriarca
    F Di Raimondo
    G Marzocchi
    M Galli
    V Montefusco
    E Zamagni
    B Gamberi
    P Tacchetti
    A Brioli
    A Palumbo
    P Sonneveld
    Leukemia, 2015, 29 : 2429 - 2431
  • [27] Bortezomib-thalidomide-dexamethasone (VTD) is superior to bortezomib-cyclophosphamide-dexamethasone (VCD) as induction therapy prior to autologous stem cell transplantation in multiple myeloma
    Cavo, M.
    Pantani, L.
    Pezzi, A.
    Petrucci, M. T.
    Patriarca, F.
    Di Raimondo, F.
    Marzocchi, G.
    Galli, M.
    Montefusco, V.
    Zamagni, E.
    Gamberi, B.
    Tacchetti, P.
    Brioli, A.
    Palumbo, A.
    Sonneveld, P.
    LEUKEMIA, 2015, 29 (12) : 2429 - 2431
  • [28] An intensive, novel chemotherapy induction regimen followed by stem cell transplantation in pts with newly diagnosed multiple myeloma (MM)
    Choy, GC
    Niesvizky, R
    Reich, L
    Wuest, D
    Nimer, S
    Michaeli, J
    BLOOD, 1996, 88 (10) : 3581 - 3581
  • [29] Initial Treatment with Bortezomib (Velcade®), Doxil®, and Dexamethasone (VDD) Is Superior to Thalidomide and Dexamethasone (TD) as Initial Therapy Prior to Autologous Stem Cell Transplantation (ASCT) for Multiple Myeloma (MM)
    Jakubowiak, Andrzej
    Kendall, Tara
    Al-Zoubi, Ammar
    Khaled, Yasser
    Mineishi, Shin
    Brozo, Christine
    Campagnaro, Erica
    Talpaz, Moshe
    Kaminski, Mark S.
    BLOOD, 2008, 112 (11) : 1273 - 1273
  • [30] Induction Therapy and Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma
    Ria, Roberto
    Reale, Antonia
    Solimando, Antonio Giovanni
    Mangialardi, Giuseppe
    Moschetta, Michele
    Gelao, Lucia
    Iodice, Giuseppe
    Vacca, Angelo
    STEM CELLS INTERNATIONAL, 2012, 2012
12345